Crossref
Engineered yeast: a breakthrough in targeted cancer therapies
The Biomedical & Life Sciences Collection · 31.03.2026 · 2026 (3) · e1008373
DOI: 10.69645/zacw4207 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Biomedical & Life Sciences Collection, online erschienen am 31.03.2026. Verfasst von Gautam Dantas.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Dantas, G. (2026). Engineered yeast: a breakthrough in targeted cancer therapies. The Biomedical & Life Sciences Collection, 2026(3), e1008373. https://doi.org/10.69645/zacw4207
Vancouver
Dantas G. Engineered yeast: a breakthrough in targeted cancer therapies. The Biomedical & Life Sciences Collection. 2026;2026(3):e1008373. doi:10.69645/zacw4207
BibTeX
@article{Dantas2026,
author = {Dantas, Gautam},
title = {Engineered yeast: a breakthrough in targeted cancer therapies},
journal = {The Biomedical & Life Sciences Collection},
year = {2026},
volume = {2026},
number = {3},
pages = {e1008373},
doi = {10.69645/zacw4207}
}
EUVIMED